ERBB2 and breast cancer: More recently, gene expression analysis with complementary DNA microarrays has been used to classify breast cancer into four molecular subtypes: luminal-A, luminal-B, human epidermal growth factor receptor-2 positive (HER2+), and TNBC [9, 10].